» Articles » PMID: 14744474

Regulation of the Norepinephrine Transporter by Chronic Administration of Antidepressants

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2004 Jan 28
PMID 14744474
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Downregulation of serotonin transporter was observed previously after chronic treatment with selective serotonin reuptake inhibitors (SSRIs) but not selective norepinephrine reuptake inhibitors (NRIs). This study investigated if chronic treatment of rats with selective NRIs or SSRIs also affected the norepinephrine transporter (NET).

Methods: Rats were treated for 3 to 6 weeks by osmotic minipumps with either the selective NRIs, desipramine, or the SSRI paroxetine.

Results: [(3)H]nisoxetine binding sites as well as [(3)H]norepinephrine uptake were decreased in hippocampus and cortex after treatment with desipramine. By contrast, paroxetine-treated rats showed no alteration in either [(3)H]nisoxetine binding or [(3)H]norepinephrine uptake. NET messenger RNA levels in the locus coeruleus were unchanged by desipramine treatment.

Conclusions: These results demonstrate that the marked decrease in NET density 1) is not a consequence of a decrease in gene expression; 2) was caused only by a selective NRI; and 3) was associated with a parallel decrease in norepinephrine uptake.

Citing Articles

Behavioral and neurochemical interactions of the tricyclic antidepressant drug desipramine with L-DOPA in 6-OHDA-lesioned rats. Implications for motor and psychiatric functions in Parkinson's disease.

Kaminska K, Lenda T, Konieczny J, Lorenc-Koci E Psychopharmacology (Berl). 2022; 239(11):3633-3656.

PMID: 36178508 PMC: 9584871. DOI: 10.1007/s00213-022-06238-x.


An Oppositional Tolerance Account for Potential Cognitive Deficits Caused by the Discontinuation of Antidepressant Drugs.

Colzato L, Zhang W, Walter H, Beste C, Stock A Pharmacopsychiatry. 2021; 54(6):252-260.

PMID: 34293810 PMC: 8575552. DOI: 10.1055/a-1520-4784.


Reduction of depression-like behavior in rat model induced by ShRNA targeting norepinephrine transporter in locus coeruleus.

Du X, Yin M, Yuan L, Zhang G, Fan Y, Li Z Transl Psychiatry. 2020; 10(1):130.

PMID: 32366842 PMC: 7198598. DOI: 10.1038/s41398-020-0808-8.


Antidepressant Withdrawal and Rebound Phenomena.

Henssler J, Heinz A, Brandt L, Bschor T Dtsch Arztebl Int. 2019; 116(20):355-361.

PMID: 31288917 PMC: 6637660. DOI: 10.3238/arztebl.2019.0355.


Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.

Arakawa R, Stenkrona P, Takano A, Svensson J, Andersson M, Nag S Int J Neuropsychopharmacol. 2019; 22(4):278-285.

PMID: 30649319 PMC: 6441126. DOI: 10.1093/ijnp/pyz003.